文献速递脑血管病神经重症与神经感染

牛磺酸减轻大鼠栓塞性卒中后tPA诱导的出血和微血管血栓形成

Taurine Reduces tPA (Tissue-Type Plasminogen Activator)-Induced Hemorrhage and Microvascular Thrombosis After Embolic Stroke in Rat.
PubMed 文献 · Stroke · 2018-05-29

在大鼠栓塞性大脑中动脉闭塞模型中,4小时给予牛磺酸(50 mg/kg)联合6小时给予tPA(10 mg/kg)可减小梗死体积和神经功能缺损,防止tPA相关出血并改善微血管通畅,机制与抑制CD147依赖性MMP-9通路有关,联合治疗还改善至少45天长期结局。

要点

  • 牛磺酸(50 mg/kg,4小时)联合tPA(10 mg/kg,6小时)减小梗死体积和神经功能缺损。
  • 联合治疗防止tPA相关脑出血并减少微血管内纤维蛋白/纤维蛋白原和血小板沉积。
  • 保护作用与抑制缺血脑内皮CD147依赖性MMP-9通路有关。

核心结论

  • 牛磺酸联合tPA可能是一种临床可行的未来卒中联合治疗思路。

研究设计与样本

  • 大鼠栓塞性大脑中动脉闭塞模型,牛磺酸(50 mg/kg)于4小时联合tPA(10 mg/kg)于6小时给药。
  • 对照组为4小时给牛磺酸(50 mg/kg)或生理盐水、或大脑中动脉闭塞后2或6小时单独给tPA(10 mg/kg)的缺血大鼠。

主要发现

  • 牛磺酸联合tPA在卒中后3天显著减小梗死体积和神经功能缺损,而单用牛磺酸保护作用较弱。
  • 6小时单用tPA对梗死体积无影响,反而诱导脑内出血。
  • 联合治疗防止tPA相关出血,减少下游微血管内纤维蛋白/纤维蛋白原和血小板沉积,改善微血管通畅。
  • 保护作用与牛磺酸深度抑制缺血脑内皮CD147依赖性MMP-9通路相关。
  • 脑室内注射大鼠CD147 siRNA靶向抑制CD147,深度抑制缺血诱导和tPA增强的缺血脑内皮MMP-9活性,并阻断tPA诱导的脑出血。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Taurine (2-aminoethansulfolic amino acid) exerts neuroprotective actions in experimental stroke. Here, we investigated the effect of taurine in combination with delayed tPA (tissue-type plasminogen activator) on embolic stroke. METHODS: Rats subjected to embolic middle cerebral artery occlusion were treated with taurine (50 mg/kg) at 4 hours in combination with tPA (10 mg/kg) at 6 hours. Control groups consisted of ischemic rats treated with either taurine (50 mg/kg) or saline at 4 hours or tPA (10 mg/kg) alone at 2 or 6 hours after middle cerebral artery occlusion. RESULTS: We found that combination treatment with taurine and tPA robustly reduced infarct volume and neurological deficits 3 days after stroke, whereas treatment with taurine alone had a less-significant protective effect. tPA alone at 6 hours had no effects on infarct volume but instead induced intracerebral hemorrhage. The combination treatment with taurine prevented tPA-associated hemorrhage and reduced intravascular deposition of fibrin/fibrinogen and platelets in downstream microvessels and hence improved microvascular patency. These protective effects are associated with profound inhibition of CD147 (cluster of differentiation 147)-dependent MMP-9 (matrix metalloproteinase-9) pathway in ischemic brain endothelium by taurine. Notably, targeted inhibition of CD147 by intracerebroventricular injection of the rat CD147 siRNA profoundly inhibited ischemia-induced and tPA-enhanced MMP-9 activity in ischemic brain endothelium and blocked tPA-induced cerebral hemorrhage. Finally, the combination treatment with taurine and tPA improved long-term outcome at least 45 days after stroke compared with saline-treated group. CONCLUSIONS: Our results suggest that taurine in combination with tPA may be a clinically feasible approach toward future attempts at combination stroke therapy.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Jin R, Xiao AY, Liu S, et al. Taurine Reduces tPA (Tissue-Type Plasminogen Activator)-Induced Hemorrhage and Microvascular Thrombosis After Embolic Stroke in Rat. Stroke. 2018. PMID: 29844028. doi:10.1161/STROKEAHA.118.020747

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。